TerrAscend (TSNDF) Capital Leases (2021 - 2024)

TerrAscend (TSNDF) reported Capital Leases of $2.1 million for Q2 2024, little changed year-over-year from $2.1 million in Q3 2023, and up 458.75% quarter-over-quarter from $383000.0 in Q1 2024.

TerrAscend (TSNDF) Capital Leases (2021 - 2024) Analysis & Trends

TerrAscend (TSNDF) has 4 years of Capital Leases data on file, last reported at $2.1 million in Q2 2024.

  • Capital Leases for Q2 2024 came in at $2.1 million, changed 0.05% year-over-year; the trailing twelve-month figure through Jun 2024 was $2.1 million (changed 0.05% YoY), and the FY2023 annual result was $407000.0, down 93.94% from the prior year.
  • Capital Leases climbed to $2.1 million in Q2 2024 per TSNDF's latest filing, from $383000.0 in the prior quarter.
  • Over five years, Capital Leases peaked at $6.7 million in Q4 2022 and troughed at $181000.0 in Q4 2021.
  • A 4-year average of $2.9 million and a median of $2.1 million in 2023 frame the typical range for Capital Leases.
  • The sharpest annual moves came in 2022 and 2024: Capital Leases jumped 3608.84% in 2022, then plunged 94.21% in 2024.
  • A 4-year view of Capital Leases shows it stood at $181000.0 in 2021, then jumped by 3608.84% to $6.7 million in 2022, then plunged by 93.94% to $407000.0 in 2023, then soared by 425.8% to $2.1 million in 2024.
  • Business Quant data shows TSNDF's Capital Leases at $2.1 million in Q2 2024, $383000.0 in Q1 2024, and $407000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 TerrAscend - - 34.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 2.14 Mn
Mar 31, 2024 383,000.00
Dec 31, 2023 407,000.00
Sep 30, 2023 571,000.00
Jun 30, 2023 2.14 Mn
Mar 31, 2023 6.61 Mn
Dec 31, 2022 6.71 Mn
Sep 30, 2022 4.70 Mn
Jun 30, 2022 4.79 Mn
Dec 31, 2021 181,000.00